Never miss a trade again with the fastest news alerts in the world!
 This headline only article is a sample of real-time intelligence
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Benzinga Pro</a> traders use to win in the markets everyday.
 Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters?
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Join 10,000+ serious traders in the Benzinga Pro community!</a>

WIIM

Silo Pharma shares are trading higher after the company announced it was awarded a US patent for its PTSD treatment titled 'Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.' - SILO Pharma (NASDAQ:SILO)

Benzinga Newsdesk

SILO Pharma

SILO

Silo Pharma shares are trading higher after the company announced it was awarded a US patent for its PTSD treatment titled 'Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.'

Comments